BioCentury
ARTICLE | Company News

Illumina, GlaxoSmithKline in pharmacogenetics deal

June 29, 2001 7:00 AM UTC

ILMN will use its BeadArray technology to determine the frequency of specified SNPs in a sample collection from GlaxoSmithKline (GSK; LSE:GSK). ...